Meril Life Sciences Pvt Ltd, Product Pipeline Analysis - 2019 Update - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Meril Life Sciences Pvt Ltd - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering.

Summary

Meril Life Sciences Pvt Ltd (Meril) is a medical device company that develops and designs clinically relevant devices. The company's product categories include cardiovascular devices, vascular interventional devices, orthopedic devices, in-vitro diagnostics devices and endo-surgery devices. It offers coronary drug eluting stents, coronary bare metal stents, PTCA balloon dilatation catheter, bioresorbable scaffold, trans-catheters, knee systems and acetabular cup systems, IVD analyzers and reagents, surgical sutures, tissue sealants, absorbable hemostats, mesh, intra uterine devices, access devices, lab consumables, energy devices and staplers, accessories, and others. The company markets its products through direct sales, distributors and representatives offices located in India, Germany, Turkey, the US, China and Brazil. Meril is headquartered in Vapi, Gujarat, India.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

• The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
• The report analyzes all pipeline products in development for the company Meril Life Sciences Pvt Ltd
• The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
• The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
• The report provides detailed description of products in development, technical specification and functions
• The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

• Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
• Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
• To formulate effective Research & Development strategies
• Develop market-entry and market expansion strategies
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
• Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Key Topics Covered:

• Meril Life Sciences Pvt Ltd Company Overview
• Meril Life Sciences Pvt Ltd Company Snapshot
• Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview
• Meril Life Sciences Pvt Ltd - Pipeline Analysis Overview
• Meril Life Sciences Pvt Ltd - Key Facts
• Meril Life Sciences Pvt Ltd - Major Products and Services
• Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage
• Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status
• Meril Life Sciences Pvt Ltd Pipeline Products Overview
• Credence - Peripheral BRS
• Credence - Peripheral BRS Product Overview
• Credence - Peripheral BRS Clinical Trial
• MeRes100
• MeRes100 Product Overview
• MeRes100 Clinical Trial
• Myval Transcatheter Aortic Valve Replacement System - Extended Size
• Myval Transcatheter Aortic Valve Replacement System - Extended Size Product Overview
• Meril Life Sciences Pvt Ltd - Key Competitors
• Meril Life Sciences Pvt Ltd - Key Employees
• Meril Life Sciences Pvt Ltd - Locations And Subsidiaries
• Head Office
• Other Locations & Subsidiaries
• Recent Developments
• Meril Life Sciences Pvt Ltd, Recent Developments
• Nov 18, 2019: MyVal transcatheter heart valve reports positive trial results
• Jul 11, 2019: MeRes100 BRS - the world's first thin strut sirolimus-eluting bioresorbable vascular scaffold - shows consistent long-term positive safety with consistent low mace rates and zero scaffold stent thrombosis for patients with coronary artery disease
• Appendix
• Methodology
• About the Author
• Contact Us
• Disclaimer

Companies Mentioned

• Sterimed Medical Devices Pvt Ltd
• Teleflex Medical Private Limited
• JK Medical Systems Pvt Ltd

For more information about this company profile visit https://www.researchandmarkets.com/r/wncxjy